MFAP4 serves as a surrogate for gene expression levels in serum, facilitating its convenient measurement, which potentially enables a more accessible assessment of liver fibrosis severity using serum biomarkers in clinical practice. This evidence concerns the gene MFAP4 and Hepatic fibrosis.